Abstract
The safety of post-myelogram computed tomography (PMCT) as an additional diagnostic procedure to metrizamide myelography was evaluated. One hundred and four consecutive patients with suspected cervical cord lesions were studied prospectively; 50 had both myelography and PMCT, and the 54 acting as controls had only myelography. PMCT did not increase the incidence, severity or duration of common side effects and the majority of patients accepted this additional procedure. It is concluded that as long as care is taken to avoid the occurrence of excessive contrast in the intracranial subarachnoid space, PMCT is a safe procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
